Optigenex Inc. announced the signing with RFI, LLC of a new, non-exclusive Supply and Trademark License Agreement for the territory of North America. The new agreement renews the parties' several year-long business relationship and extends continuing rights to RFI to manufacture and market dietary supplement products containing AC-11(R) (formerly known as C-Med-100(R)). Both parties anticipate that this timely recommitment will reap mutual benefits, as the growing body of AC-11(R) scientific validation recently has opened several new doors for capitalizing on Optigenex's patented technology, especially in the novel field of advanced, oral-based sun care products.

Optigenex Inc. announced the introduction of AC-11(R)-melon, a new oral capsule formulated by its partner, Itochu Corp., utilizing patented AC-11(R) in combination with GliSODin, a cantaloupe melon extract rich in the vegetable antioxidant enzyme (SOD). The protective benefits of GliSODin, in conjunction with the therapeutic benefits of AC-11(R) to help repair naturally the body's damaged DNA, offer a unique and highly effective combination for cellular wellness to health-conscious consumers. Japan traditionally has been known for its highly educated and well-informed consumer population, especially in the area of healthy aging. The enthusiastic response to Koyo-sa Japan's rollout of AC-11(R)-melon validates this reputation and constitutes another step forward in the evolution of AC-11(R) as one of the most popular health and wellness technologies in Japan. Itochu acts in partnership with Optigenex under a Long-Term Exclusive Supply and Trademark Licensing Agreement to market AC-11(R) bulk material and consumer products containing AC-11(R) under sublicenses in Japan and several other Asian countries.

Optigenex Inc. announced the signing of a long term exclusive license agreement with Promethean Corporation for distribution and marketing of branded cosmeceutical and dietary supplement products containing AC-11(R), a patented, all-natural rain forest botanical extract manufactured by Optigenex that helps the body's natural ability to repair damaged DNA as a result of overexposure to the sun and other environmental stressors. Under the new agreement, Promethean through its wholly owned subsidiary, Ceres Living will market the "AIO Premium Cellular Health(TM)" line of advanced dietary supplements, as well as specially formulated next generation topical skin care products with AC-11(R). The contract vests Promethean with exclusivity in the North American "Direct Sales" or "Network Marketing" distribution channel coinciding with the expiration of similar channel rights previously held by former licensee. In addition to North American Direct Sales channel rights, Promethean will exercise exclusive rights and sublicensing rights in all channels in China and certain additional non-exclusive channel rights in North and Central America and Australia.

Optigenex Inc. Renews Its Agreement With RFI Ingredients for Marketing and Sale of AC-11(R) in Retail and Direct to Physician Channels (Financial Terms Were Not Disclosed)

Optigenex Inc. Renews Its Agreement With RFI Ingredients for Marketing and Sale of AC-11(R) in Retail and Direct to Physician Channels (Financial Terms Were Not Disclosed)

Optigenex Inc. Announces Expansion of AC-11(R) Sales in Japan Through Its Exclusive Partner Itochu Corporation

Optigenex Inc. Announces Expansion of AC-11(R) Sales in Japan Through Its Exclusive Partner Itochu Corporation

Optigenex Inc. Announces New Business to Business Web Site to Target Select Marketing and Manufacturing Companies in the Skin Care and Wellness Industries

Optigenex Inc. Announces Supply And License Agreement With Suracell Inc. To Utilize The AC-11(R) Trademark And Technology For Oral Supplements In The United States, Canada And South Korea

Optigenex Inc. Announces Rollout of Activar(R) AC-11(R) Oral Supplements and Activar(R) AC-11(R) Next Generation Skin Care Products in Turkey Through Its Middle Eastern Distribution Partner Ekson Farma, Istanbul

Optigenex Inc. Agrees to Long-Term License Granting Promethean Corporation Exclusive North American Distribution Rights for Cosmeceutical and Dietary Supplement Products Containing AC-11(R) in the Direct Sales (Network Marketing) Distributi

Optigenex Inc. Agrees to Long-Term License Granting Promethean Corporation Exclusive North American Distribution Rights for Cosmeceutical and Dietary Supplement Products Containing AC-11(R) in the Direct Sales (Network Marketing) Distributi

Optigenex Inc. Announces Rollout of Activar(R) AC-11(R) Oral Supplements and Activar(R) AC-11(R) Next Generation Skin Care Products in Turkey Through Its Middle Eastern Distribution Partner Ekson Farma, Istanbul

Optigenex Inc. Announces Supply And License Agreement With Suracell Inc. To Utilize The AC-11(R) Trademark And Technology For Oral Supplements In The United States, Canada And South Korea

Optigenex Inc. Announces New Business to Business Web Site to Target Select Marketing and Manufacturing Companies in the Skin Care and Wellness Industries